ScreenerHero
ALBPSBiophytis S.A.
EPA · FR · Healthcare · Biotechnology · biophytis.com
0.1058EUR-14.68%Mkt Cap: 15.72M $P/E: —

Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients with age-related diseases. The company'…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
argenx SE
$61.34BUSDP/E 39.8
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap15.72M $
Enterprise Value10.24M $
Revenue (TTM)—
Gross Profit0 $
Net Income (TTM)-8.73M $
Revenue/Share—
Last Price0.1058 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees19
CountryFR
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.06
PEG—
EV/EBITDA-1.20
EV/Revenue—
P/S—
P/B-0.38
EPS (TTM)-0.34
EPS (Forward)-2.15
52W Range
0.004250% of range0.2075
52W High0.2075 EUR
52W Low0.0042 EUR
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE—
ROA-66.56%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.39M $
CapEx (TTM)—
FCF Margin—
FCF Yield-11.32%
Net Debt7.08M $
Net Debt/EBITDA-0.83
Balance Sheet
Debt/Equity-0.68
Current Ratio0.35
Quick Ratio0.33
Book Value/Sh-0.3330 EUR
Cash/Share0.0520 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:400
Split DateMay 3, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.137.70M
Float23.36M
Insiders1.34%
Institutions1.38%
Technical
SMA 500.0268 (+295.0%)
SMA 2000.0419 (+152.4%)
Beta0.85
S&P 52W Chg18.16%
Avg Vol (30d)33.81M
Avg Vol (10d)70.19M
Technical Indicators
RSI (14)80.3
MACD0.0244
MACD Signal0.0132
MACD Hist.+0.0113
BB Upper0.1254 EUR
BB Middle0.0457 EUR
BB Lower-0.0341 EUR
BB Width349.32%
ATR (14)0.0172 EUR
Vol Ratio (20d)1.28x